Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 11 (RBM11) is a nuclear, tissue-specific RNA-binding protein that regulates alternative splicing primarily in the brain, cerebellum, testis, and, to a lesser extent, kidney[2][3][4]. It contains an amino-terminal RNA recognition motif (RRM) responsible for RNA binding, and a carboxyl-terminal region that allows nuclear localization and homodimerization[2][3]. RBM11 modulates selection of 5' splice sites by binding to specific RNA sequences (such as in BCL-X exon 2), antagonizing the activity of SR proteins like SRSF1, and is enriched in nuclear "splicing speckles"[2][3][4]. It affects differentiation events during neuronal and germ cell development and exhibits dynamic intra-nuclear localization in response to transcriptional activity or cellular stress[2][3]. Aberrant expression or function of RBM11 may contribute to disease, including cancer, by altering splicing events critical to cell fate[1][4].
Not established; since no drugs directly target RBM11, there are no confirmed mechanisms of action
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA binding motif protein 11 (RBM11).